|
Orthologous residues
|
|
PKCD (human): T507‑p, PKCD iso13 (human): T507‑p, PKCD (mouse): T505‑p, PKCD iso2 (mouse): T531‑p, PKCD (rat): T505‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
immunoprecipitation, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
parotid acinar-salivary gland
|
|
Cellular systems studied:
primary cultured cells
|
|
Species studied:
rat
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
phorbol ester
|
|
|
|
no change compared to control
|
|
|
phorbol ester, LY294002
|
|
|
|
no change compared to control
|
|
|
phorbol ester, rapamycin
|
|
|
|
no change compared to control
|
|
|
LY294002
|
|
|
|
no change compared to control
|
|
|
rapamycin
|
|
|
|
no change compared to control
|
|
|
wortmannin
|
|
|
|
no change compared to control
|
|
|
carbachol
|
|
|
|
no change compared to control
|
|
|
carbachol
|
|
|
|
no change compared to control
|
|
|
carbachol
|
|
|
|
no change compared to control
|
|
|